Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.3.2022CHEPLAPHARM Registration GmbH (CEP-2)64308ZYPADHERA 405 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x405 mg (liek.inj.skl.) +1x3 ml solv.(liek.inj.skl.))14.3.2022O
 14.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)02085Zeffix 100 mg filmom obalené tablety (tbl flm 28x100 mg (blis.Al/PVC))25.2.2022R
 11.3.2022OMEDICAMED, UNIPESSOAL LDA (OMD)37443BRONCHO-VAXOM pre deti (plv por 1x30 vreciek)11.3.2022R
 11.3.2022B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))11.3.2022O
 11.3.2022CANDE s.r.o. (CRR-SK)7204CCEFIMED 200 mg (tbl flm 10x200 mg (blis.PVC/PA/Al/PVC/Al))15.3.2022R
 11.3.2022Viatris Healthcare Limited (VIM-1)53853KLACID 500 mg filmom obalené tablety (tbl flm 14x500 mg (blis.PVC/PVDC/Al))14.3.2022O
 10.3.2022B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))7.3.2022R
 10.3.2022Fresenius Kabi AB (FRE)43084SOLUVIT N (lyo ifo 1x10 (liek.inj.skl.))10.3.2022O
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8778ATRIPLIXAM 5 mg/1,25 mg/5 mg (tbl flm 30x5 mg/1,25 mg/5 mg (obal PP))10.3.2022R
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8780ATRIPLIXAM 5 mg/1,25 mg/5 mg (tbl flm 90(3x30)x5 mg/1,25 mg/5 mg (obal PP))10.3.2022R
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8793ATRIPLIXAM 10 mg/2,5 mg/10 mg (tbl flm 30x10 mg/2,5 mg/10 mg (obal PP))10.3.2022R
 10.3.2022Mylan IRE Healthcare Limited (MYR)56801KLACID I.V. (plc ifc 1x500 mg (liek.inj.skl.))10.3.2022O
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8790ATRIPLIXAM 10 mg/2,5 mg/5 mg (tbl flm 90(3x30)x10 mg/2,5 mg/5 mg (obal PP))10.3.2022R
 10.3.2022KRKA, d.d., Novo mesto (KRK-2)0667DValtricom 5 mg/160 mg/12,5 mg filmom obalené tablety (tbl flm 90x5 mg/160 mg/12,5 mg (blis.OPA/Al/PVC/Al))14.3.2022O
 10.3.2022KRKA, d.d., Novo mesto (KRK-2)8137ASobycor 2,5 mg filmom obalené tablety (tbl flm 30x2,5 mg (blis.Al/Al))14.3.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)